User profiles for "author:Chaoyi Zheng"

Chaoyi Zheng

NORC at the University of Chicago
Verified email at norc.org
Cited by 393

Can synthetic data be a proxy for real clinical trial data? A validation study

Z Azizi, C Zheng, L Mosquera, L Pilote, K El Emam - BMJ open, 2021 - bmjopen.bmj.com
Objectives There are increasing requirements to make research data, especially clinical trial
data, more broadly available for secondary analyses. However, data availability remains a …

Fragmentation of care after surgical discharge: non-index readmission after major cancer surgery

C Zheng, EB Habermann, NM Shara… - Journal of the American …, 2016 - Elsevier
Background Despite national emphasis on care coordination, little is known about how
fragmentation affects cancer surgery outcomes. Our study examines a specific form of …

Optimizing the synthesis of clinical trial data using sequential trees

KE Emam, L Mosquera, C Zheng - Journal of the American …, 2021 - academic.oup.com
Objective With the growing demand for sharing clinical trial data, scalable methods to
enable privacy protective access to high-utility data are needed. Data synthesis is one such …

[HTML][HTML] An improved state of charge and state of power estimation method based on genetic particle filter for lithium-ion batteries

X Liu, C Zheng, J Wu, J Meng, DI Stroe, J Chen - Energies, 2020 - mdpi.com
In this paper, an improved method for estimating the state of charge (SOC) of lithium-ion
batteries is proposed, which is developed from the particle filter (PF). An improved genetic …

Why do long-distance travelers have improved pancreatectomy outcomes?

M Jindal, C Zheng, HS Quadri, CU Ihemelandu… - Journal of the American …, 2017 - Elsevier
Background Centralization of complex surgical care has led patients to travel longer
distances. Emerging evidence suggested a negative association between increased travel …

Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma

S Jang, C Zheng, HT Tsai, AZ Fu, A Barac, MB Atkins… - Cancer, 2016 - Wiley Online Library
BACKGROUND Sorafenib and sunitinib are oral vascular endothelial growth factor receptor
(VEGFR) tyrosine kinase inhibitors (TKIs) approved in 2005 and 2006, respectively, for the …

Medicaid expansion and disparity reduction in surgical cancer care at high-quality hospitals

D Xiao, C Zheng, M Jindal, LB Johnson… - Journal of the American …, 2018 - Elsevier
Background The Affordable Care Act's Medicaid expansion has been heavily debated due
to skepticism about Medicaid's ability to provide high-quality care. Particularly, little is known …

Histone deacetylase cytoplasmic trapping by a novel fluorescent HDAC inhibitor

Y Kong, M Jung, K Wang, S Grindrod, A Velena… - Molecular cancer …, 2011 - AACR
Inhibitors of histone deacetylases (HDAC) are an important emerging class of drugs for the
treatment of cancers. HDAC inhibitors are currently under evaluation in clinical trials as …

Did pre-Affordable Care Act Medicaid expansion increase access to surgical cancer care?

WB Al-Refaie, C Zheng, M Jindal… - Journal of the …, 2017 - journals.lww.com
BACKGROUND: Although the Affordable Care Act (ACA) expanded Medicaid access, it is
unknown whether this has led to greater access to complex surgical care. Evidence on the …

Type 2 diabetes among 6 Asian ethnic groups in California: the nexus of ethnicity, gender, and generational status

ZJ Huang, C Zheng - Journal of Health Care for the Poor and …, 2015 - muse.jhu.edu
Objectives. We examined associations between generational status and age-adjusted type
2 diabetes (T2DM) among Asians living in California. Methods. We abstracted data on 7,188 …